11:34 AM EST, 11/28/2024 (MT Newswires) -- HYTN Innovations ( HYTNF ) specializing in psychoactive and psychotropic compounds, on Thursday said it received the initial orders and import permits from the UK's 4C Labs, allowing HYTN to begin exporting premium cannabis-based pharmaceuticals to the UK under the company's recently established agreements.

"We are thrilled to take this next step with 4C Labs," said chief executive Elliot McKerr. "This milestone underscores the strength of our collaboration and signals the shift from a domestic to international cannabis company."

HYTN is also registered on the UK's National Drugs Control System.

The company's shares were last seen down $0.01 to $0.25 on the Canadian Securities Exchange.

Price: 0.25, Change: -0.01, Percent Change: -3.85